Tamura J, Sato N, Ezaki H, Yokoyama S
J Toxicol Sci. 1983 Jan;8 Suppl 1:141-50. doi: 10.2131/jts.8.supplementi_141.
Ranitidine hydrochloride, a histamine H2-receptor antagonist, was orally given to pregnant rabbits of Japanese White strain from day 6 to 18 of gestation at doses of 25, 100 and 400 mg/kg/day, as ranitidine base, and teratogenicity of the drug was studied. The results were as follows: (1) At dose of 400 mg/kg/day, ranitidine hydrochloride showed no effects on dams, excepting slight suppression in body weight gain in early period of administration. (2) In fetuses, no effects of ranitidine hydrochloride on fetal growth, sex ratio, viability and degree of ossification were observed. (3) External and visceral abnormalities were observed 5, 3, 3 and 4 fetuses in control, 25, 100 and 400 mg/kg/day groups, respectively, but there was no significant difference of the incidence ratio in the treated groups from control, and was no increase in the same type of abnormality. Ranitidine hydrochloride induced no increase in incidence of visceral and skeletal variations. Therefore it was concluded that ranitidine hydrochloride had no teratogenic effect on rabbits at dose of 400 mg/kg/day or lower than that.
盐酸雷尼替丁是一种组胺H2受体拮抗剂,在妊娠第6天至18天,以25、100和400mg/kg/天的剂量(以雷尼替丁碱计)口服给予日本白色品系妊娠兔,并研究该药物的致畸性。结果如下:(1)在400mg/kg/天的剂量下,盐酸雷尼替丁对母兔无影响,仅在给药早期体重增加略有抑制。(2)在胎儿方面,未观察到盐酸雷尼替丁对胎儿生长、性别比例、活力和骨化程度的影响。(3)在对照组、25、100和400mg/kg/天组中,分别有5、3、3和4只胎儿出现外部和内脏异常,但各治疗组的发生率与对照组相比无显著差异,且同一类型的异常也未增加。盐酸雷尼替丁未导致内脏和骨骼变异发生率增加。因此得出结论,盐酸雷尼替丁在400mg/kg/天或更低剂量时对兔无致畸作用。